scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q2 EPS of ($0.36), $0.01 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $1.64 million versus the consensus estimate of $1.45 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.